HOME > ARCHIVE
ARCHIVE
- Japanese Firms May Not Feel Pain If There Is Pain: Mr Kobayashi of PhRMA
May 26, 2003
- Annual Business Results
May 26, 2003
- JPMA General Assembly
May 26, 2003
- ON THE MOVE
May 26, 2003
- Dear-Doctor Letter Doesn't Decrease Panaldine ADR Reports
May 26, 2003
- Wyeth Stresses Significance of Enbrel: Mr Essner
May 26, 2003
- Daiichi: R&D Spending, NHI Price Cuts Hit Sales, Profits
May 19, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
May 19, 2003
- Teijin: Pharma Sales Down 2.2% to \92.5 Bil.
May 19, 2003
- GENKY Stores to Go Public Next Month
May 19, 2003
- Freund: Sales Down 12.3%, Net Profits Down 94.7%
May 19, 2003
- DIAGNOSTIC NEWS IN BRIEF
May 19, 2003
- Usefulness of Novacor LVAS Discussed: Edwards Lifesciences
May 19, 2003
- JSMI Approves FY2003 Activity Plan
May 19, 2003
- WORLD NEWS IN BRIEF
May 19, 2003
- New Drugs Including Remicade, Pitavastatin Recommended for Approval
May 19, 2003
- CAWACHI YAKUHIN: Ordinary Profits Up 17% to \10.6 Bil.
May 19, 2003
- WEBSITE NEWS
May 19, 2003
- Package Insert to Be Revised for Pazufloxacin, Lithium Carbonate
May 19, 2003
- Pharmacists Needed in Discussions on OTC Deregulation: JPA
May 19, 2003
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
